These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 13831423)

  • 21. MONOAMINE oxidase inhibitors.
    Br Med J; 1959 Dec; 2(5161):1238. PubMed ID: 13856860
    [No Abstract]   [Full Text] [Related]  

  • 22. [Monoamine oxidase inhibitors].
    MACIAS CASTRO I
    Arch Hosp Univ; 1960; 12():330-3. PubMed ID: 13764845
    [No Abstract]   [Full Text] [Related]  

  • 23. Stereospecificity of monoamine oxidase inhibitors.
    PLETSCHER A; GEY KF
    Science; 1958 Oct; 128(3329):900-1. PubMed ID: 13592273
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent biochemical developments with monoamine oxidase inhibitors.
    SHORE PA
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():62-3. PubMed ID: 14446179
    [No Abstract]   [Full Text] [Related]  

  • 25. [Monoamine oxidase inhibitors--a new group of drugs?].
    NAESS K
    Nord Med; 1959 Aug; 62():1251-5. PubMed ID: 14425748
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure and activity relationships of monoamine oxidase inhibitors.
    BIEL JH; NUHFER PA; CONWAY AC
    Ann N Y Acad Sci; 1959 Sep; 80():568-82. PubMed ID: 13800538
    [No Abstract]   [Full Text] [Related]  

  • 27. The interaction between reversible and irreversible monoamine oxidase inhibitors.
    HORITA A; McGRATH WR
    Biochem Pharmacol; 1960 Jun; 3():206-11. PubMed ID: 14403109
    [No Abstract]   [Full Text] [Related]  

  • 28. Behavioral determination of time and dose parameters of monoamine oxidase inhibitors.
    HEISE GA; BOFF E
    J Pharmacol Exp Ther; 1960 Jun; 129():155-62. PubMed ID: 14400778
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and pharmacological considerations on mode of action of monoamine oxidase inhibitors.
    ZBINDEN G; RANDALL LO; MOE RA
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():89-100. PubMed ID: 13855472
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiac activities of several monoamine oxidase inhibitors.
    LEE WC; SHIN WH; SHIDEMAN FE
    J Pharmacol Exp Ther; 1961 Aug; 133():180-5. PubMed ID: 13760280
    [No Abstract]   [Full Text] [Related]  

  • 31. The pharmacological evaluation of monoamine oxidase inhibitors.
    LESSIN AW
    Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030
    [No Abstract]   [Full Text] [Related]  

  • 32. On the reported inhibition of monoamine oxidase by an agent with sedative properties.
    SPECTOR S; SHORE PA; BRODIE BB
    Science; 1960 Sep; 132(3429):735. PubMed ID: 13833206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticonvulsant properties of monoamine oxidase inhibitors.
    PROCKOP DJ; SHORE PA; BRODIE BB
    Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994
    [No Abstract]   [Full Text] [Related]  

  • 34. [On monoamine-oxidase inhibitors].
    KROEBER E
    Psychiatr Neurol (Basel); 1960 Jul; 140():92-6. PubMed ID: 13754442
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppression of increased capillary permeability in injury by monoamine oxidase inhibitors.
    SPECTOR WG; WILLOUGHBY DA
    Nature; 1960 Apr; 186():162-3. PubMed ID: 13833208
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoamine oxidase inhibitors and angina pectoris.
    WINSOR T; ZARCO P
    Angiology; 1960 Feb; 11():67-75. PubMed ID: 13845298
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical toxicity studies of a monoamine oxidase inhibitor.
    GREENBLATT IJ; KAHN A
    Ann N Y Acad Sci; 1959 Sep; 80():947-59. PubMed ID: 13851575
    [No Abstract]   [Full Text] [Related]  

  • 38. A monoamine oxidase inhibitor in the treatment of organic disease.
    MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoamine oxidase inhibitors and procedures for their evaluation in vivo and in vitro.
    OZAKI M; WEISSBACH H; OZAKI A; WITKOP B; UDENFRIEND S
    J Med Pharm Chem; 1960 Dec; 2():591-607. PubMed ID: 13731832
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain.
    BRODIE BB; SPECTOR S; SHORE PA
    Ann N Y Acad Sci; 1959 Sep; 80():609-16. PubMed ID: 13804624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.